Literature DB >> 25896235

Tonsillectomy and Risk of Oropharyngeal Cancer: Implications for Research and Prevention.

Anil K Chaturvedi1.   

Abstract

The association of tonsillectomy, a common surgical procedure involving the removal of a majority of the palatine tonsillar tissue, with risk of tonsil cancer specifically or oropharyngeal cancers overall is not known. In this issue of Cancer Prevention Research, Fakhry and colleagues conduct an analysis within the Danish Cancer Registry and show that tonsillectomies were associated with significantly reduced risk of tonsil cancer, but were unrelated to risk of base of tongue cancers. This editorial discusses the implications of the results by Fakhry and colleagues for key prevailing questions in the field related to risk, rising incidence, secondary prevention, and treatment of oropharyngeal cancers. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 25896235     DOI: 10.1158/1940-6207.CAPR-15-0135

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  2 in total

1.  Previous tonsillectomy modifies odds of tonsil and base of tongue cancer.

Authors:  Jose P Zevallos; Angela L Mazul; Nidia Rodriguez; Mark C Weissler; Paul Brennan; Devasena Anantharaman; Behnoush Abedi-Ardekani; D Neil Hayes; Andrew F Olshan
Journal:  Br J Cancer       Date:  2016-03-15       Impact factor: 7.640

2.  HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology.

Authors:  Andrew G Schache; Ned G Powell; Kate S Cuschieri; Max Robinson; Sam Leary; Hisham Mehanna; Davy Rapozo; Anna Long; Heather Cubie; Elizabeth Junor; Hannah Monaghan; Kevin J Harrington; Christopher M Nutting; Ulrike Schick; Andy S Lau; Navdeep Upile; Jon Sheard; Kath Brougham; Catharine M L West; Ken Oguejiofor; Steve Thomas; Andy R Ness; Miranda Pring; Gareth J Thomas; Emma V King; Dennis J McCance; Jacqueline A James; Michael Moran; Phil Sloan; Richard J Shaw; Mererid Evans; Terry M Jones
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 13.312

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.